FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines

I. Ei-Hariry, M. Pignatelli, N. R. Lemoine

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) have been increasingly recognized to play an important role in the pathobiology of pancreatic malignancy. We have investigated the effects of FGF-1 and FGF-2 on the behaviour and adhesion properties of human pancreatic adenocarcinoma cell lines (BxPc3, T3M4 and HPAF) that were previously characterised for the expression of FGFRs. Here we show that exposure to FGF-1 and FGF-2 leads to significant and dose-dependent increase in E-cadherin-dependent cell-cell adhesion, tubular differentiation, and a reduced capacity to invade collagen gels. FGF stimulation produces phosphorylation of E-cadherin and β-catenin on tyrosine residues, as well as increased E-cadherin localisation to the cytoplasmic membrane and association with FGFR1 demonstrable by coimmunoprecipitation. These results demonstrate that FGF-1 and FGF-2 may be involved in the regulation of cell adhesion, differentiation and invasion of pancreatic cancer.

Original languageEnglish
Pages (from-to)1656-1663
Number of pages8
JournalBritish Journal of Cancer
Volume84
Issue number12
DOIs
Publication statusPublished - Jun 15 2001
Externally publishedYes

Fingerprint

Fibroblast Growth Factor 1
Catenins
Fibroblast Growth Factor 2
Cadherins
Fibroblast Growth Factor Receptors
Adenocarcinoma
Fibroblast Growth Factors
Cell Adhesion
Cell Line
Pancreatic Neoplasms
Tyrosine
Cell Differentiation
Collagen
Gels
Phosphorylation
Cell Membrane
Neoplasms

Keywords

  • Catenins
  • E-cadherin
  • FGF
  • FGFR
  • Pancreatic adenocarcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines. / Ei-Hariry, I.; Pignatelli, M.; Lemoine, N. R.

In: British Journal of Cancer, Vol. 84, No. 12, 15.06.2001, p. 1656-1663.

Research output: Contribution to journalArticle

@article{4e9209077ae743ca9246d12d89520a66,
title = "FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines",
abstract = "Fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) have been increasingly recognized to play an important role in the pathobiology of pancreatic malignancy. We have investigated the effects of FGF-1 and FGF-2 on the behaviour and adhesion properties of human pancreatic adenocarcinoma cell lines (BxPc3, T3M4 and HPAF) that were previously characterised for the expression of FGFRs. Here we show that exposure to FGF-1 and FGF-2 leads to significant and dose-dependent increase in E-cadherin-dependent cell-cell adhesion, tubular differentiation, and a reduced capacity to invade collagen gels. FGF stimulation produces phosphorylation of E-cadherin and β-catenin on tyrosine residues, as well as increased E-cadherin localisation to the cytoplasmic membrane and association with FGFR1 demonstrable by coimmunoprecipitation. These results demonstrate that FGF-1 and FGF-2 may be involved in the regulation of cell adhesion, differentiation and invasion of pancreatic cancer.",
keywords = "Catenins, E-cadherin, FGF, FGFR, Pancreatic adenocarcinoma",
author = "I. Ei-Hariry and M. Pignatelli and Lemoine, {N. R.}",
year = "2001",
month = "6",
day = "15",
doi = "10.1054/bjoc.2001.1813",
language = "English",
volume = "84",
pages = "1656--1663",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines

AU - Ei-Hariry, I.

AU - Pignatelli, M.

AU - Lemoine, N. R.

PY - 2001/6/15

Y1 - 2001/6/15

N2 - Fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) have been increasingly recognized to play an important role in the pathobiology of pancreatic malignancy. We have investigated the effects of FGF-1 and FGF-2 on the behaviour and adhesion properties of human pancreatic adenocarcinoma cell lines (BxPc3, T3M4 and HPAF) that were previously characterised for the expression of FGFRs. Here we show that exposure to FGF-1 and FGF-2 leads to significant and dose-dependent increase in E-cadherin-dependent cell-cell adhesion, tubular differentiation, and a reduced capacity to invade collagen gels. FGF stimulation produces phosphorylation of E-cadherin and β-catenin on tyrosine residues, as well as increased E-cadherin localisation to the cytoplasmic membrane and association with FGFR1 demonstrable by coimmunoprecipitation. These results demonstrate that FGF-1 and FGF-2 may be involved in the regulation of cell adhesion, differentiation and invasion of pancreatic cancer.

AB - Fibroblast growth factors (FGFs) and fibroblast growth factor receptors (FGFRs) have been increasingly recognized to play an important role in the pathobiology of pancreatic malignancy. We have investigated the effects of FGF-1 and FGF-2 on the behaviour and adhesion properties of human pancreatic adenocarcinoma cell lines (BxPc3, T3M4 and HPAF) that were previously characterised for the expression of FGFRs. Here we show that exposure to FGF-1 and FGF-2 leads to significant and dose-dependent increase in E-cadherin-dependent cell-cell adhesion, tubular differentiation, and a reduced capacity to invade collagen gels. FGF stimulation produces phosphorylation of E-cadherin and β-catenin on tyrosine residues, as well as increased E-cadherin localisation to the cytoplasmic membrane and association with FGFR1 demonstrable by coimmunoprecipitation. These results demonstrate that FGF-1 and FGF-2 may be involved in the regulation of cell adhesion, differentiation and invasion of pancreatic cancer.

KW - Catenins

KW - E-cadherin

KW - FGF

KW - FGFR

KW - Pancreatic adenocarcinoma

UR - http://www.scopus.com/inward/record.url?scp=0035875243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035875243&partnerID=8YFLogxK

U2 - 10.1054/bjoc.2001.1813

DO - 10.1054/bjoc.2001.1813

M3 - Article

VL - 84

SP - 1656

EP - 1663

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 12

ER -